# BD completes new syringe and needle manufacturing lines in Nebraska

BD completed new syringe and needle manufacturing lines in Holdrege, Nebraska, as part of a $70 million capital project with $42 million investment from BARDA. The expansion increases domestic capacity for safety injection devices to support U.S. vaccination efforts.

- Type: Expansion
- Announced: 2021-10-07
- Where: Holdrege, Nebraska, United States
- Value: $70.0M
- Starts operating: 7 Oct 2021
- Status: completed
- Products: needles, syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BD (Becton, Dickinson and Company)](https://endata.com/companies/23751.md)
- [Biomedical Advanced Research and Development Authority (BARDA)](https://endata.com/companies/48590.md) (investor)

## Sources

- [news.bd.com](https://news.bd.com/2021-10-07-BD-Unveils-Nebraska-Based-Manufacturing-Capacity-to-Support-U-S-Vaccination-Agility-and-Preparedness), 2021-10-07: "The new lines increase capacity of BD's existing needle and syringe supply capabilities domestically."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.